GE Healthcare (NYSE:GE) and Wayra today announced a collaboration to name seven medtech startups to the Edison Accelerator program.
The seven startups represent the second cohort of the Edison Accelerator in Europe, the Middle East and Africa (EMEA). The accelerator is a startup and scale-up program designed by GE Healthcare in partnership with UK-based Wayra.
Over the next six months, the startups will have access to GE Healthcare’s solutions and integrations. They will also have access to healthcare providers to test product innovations on existing workflows and technologies.
GE Healthcare said the program helps to develop, integrate and commercialize digital solutions. In turn, this will “drive the digital future of healthcare forward.”
“The challenges the healthcare sector is facing today are too complex for a single company to solve,” said Jan Beger, senior director of digital ecosystem, GE Healthcare. “Through Edison Accelerators, we are bringing together ideas, skills, a network and other resources. This can result in powerful innovations that generate real impact, driving digital transformation and striving for an improved patient experience.”
Companies selected for the accelerator span across four different countries. They will be presented to a network of investors, potential business partners and customers over the next six months.
Subject to regulatory authorizations, successful applications could also be distributed through GE Healthcare’s marketplace. Since the close of the first cohort in 2021, four of six startups have begun commercial onboarding with GE Healthcare.
Startups selected for GE Healthcare and Wayra’s Edison Accelerator
Alertive (U.K.): Alertive builds mobile and desktop applications that simplify teamwork for critical care workers. The technology connects them with relevant colleagues and the patient information required to make decisions at the point of care.
xWave (U.K.): A group of radiologists founded xWave Technologies in Ireland in 2020. They aim to create intelligent solutions for the problems they face in their day-to-day work.
Idoven (Spain): Idoven is developing early detection and precision medicine for cardiovascular diseases. Idoven’s AI platform delivers sustainable improvements to the speed, consistency, and accuracy of electrocardiogram interpretation. It also offers new prediction capabilities.
Nurea (France): Nurea specializes in designing and engineering SaMD. With the aim of simplifying physicians’ decision-making processes and patient-follow up, the company is working on helping radiologists and surgeons by accelerating their workflow by 60% by standardizing medical image interpretation and thus preventing accidents.
Metalynx (U.K.): Metalynx provides a software visualization platform enabling subject matter experts to develop and evaluate computer vision applications without technical training. It bridges the gap between the data domain expertise and the technical expertise needed to build robust, trustworthy AI.
Clinithink (U.K.): Clinithink is a technology company built around CLiX, the world’s first healthcare AI capable of truly understanding unstructured medical notes. CLiX can read, understand and extrapolate from the meandering mass of deductions, hunches, opinions and observations that doctors use to describe conditions in real life.
KOSA AI (The Netherlands): KOSA AI is a software tech company that builds AI governance software tools that audit, explain and monitor bias and risks throughout the MR/AI lifecycle of a product. KOSA AI supports healthcare organizations to generate more inclusive and people-centered outcomes, improving trust, efficiency and utility of AI.